Archives
Joe Lockhart Declined Jeffrey Epstein's Request for PR Help, Emails Show
Emails reveal that Joe Lockhart declined a request from Jeffrey Epstein for PR help in 2015 as sex-trafficking allegations intensified.
Target Offers Discounts Across 3,000 Products as Cost of Living Concerns Grow
Target cuts prices on over 3,000 items this spring to help families save amid rising living costs.
Medical Giant Stryker Faces Network Disruption Amid Cyberattack Claims
Medical device company Stryker faces a global network disruption after a suspected cyberattack linked to a pro-Iranian group.
IEA Releases 400 Million Barrels from Reserves to Ease Energy Prices
The International Energy Agency released 400 million barrels of oil from reserves to stabilize global energy markets disrupted by the Strait of Hormuz crisis.
Latest News
Amazon Zoox and Uber are partnering up to bring self-driving ride-hailing services to the Las Vegas and Los Angeles areas.
Buc-ee's receives an "F" rating from the Better Business Bureau after dozens of unresolved customer complaints about service, pricing, and product issues.
Several Disneyland employees were hospitalized after a chemical reaction caused an unknown odor near the Star Tours attraction in Tomorrowland.
FDA officials say there is no strong evidence that leucovorin helps most people with autism despite earlier claims promoted by Donald Trump.
Oracle beats Q3 revenue forecasts, uses AI to boost productivity, restructures teams, and plans job cuts while expanding ambitious AI-driven initiatives.
Oil prices eased after briefly surging above $100 as fears of major supply disruptions from the Iran conflict began to calm.
Elon Musk's xAI received approval to build a 41-turbine natural gas power plant in Southaven, sparking community and environmental protests.
Meta has added AI social media company Moltbook to its portfolio, and it is set to power its Superintelligence Labs.
Electronic Arts has laid off its employees who have worked on the Battlefield games despite their success last year with the game.
Novo Nordisk drops its lawsuit against Hims & Hers as the companies partner to offer FDA-approved Wegovy and Ozempic through the telehealth platform.

















